Robert W. Baird Cuts Phreesia (NYSE:PHR) Price Target to $25.00

Phreesia (NYSE:PHR) had its price target decreased by Robert W. Baird from $31.00 to $25.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. Robert W. Baird currently has an outperform rating on the stock.

Several other equities analysts have also commented on PHR. Truist Financial upped their price objective on shares of Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a report on Friday, September 5th. JMP Securities upped their price target on Phreesia from $30.00 to $34.00 and gave the stock a “market outperform” rating in a research note on Monday, September 8th. JPMorgan Chase & Co. lowered their price target on Phreesia from $32.00 to $29.00 and set an “overweight” rating for the company in a research report on Tuesday. KeyCorp cut their price objective on Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a report on Wednesday, October 8th. Finally, Needham & Company LLC reissued a “buy” rating and set a $35.00 target price on shares of Phreesia in a research note on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $31.13.

Phreesia Stock Performance

Shares of Phreesia stock opened at $16.22 on Wednesday. The firm has a market cap of $977.84 million, a PE ratio of -162.17 and a beta of 0.64. The company has a quick ratio of 2.12, a current ratio of 2.44 and a debt-to-equity ratio of 0.01. Phreesia has a 52 week low of $15.41 and a 52 week high of $32.76. The business’s fifty day simple moving average is $21.46 and its 200-day simple moving average is $25.01.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.11. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. During the same period in the previous year, the firm earned ($0.25) EPS. Phreesia’s revenue was up 12.7% on a year-over-year basis. Equities analysts forecast that Phreesia will post -1.1 earnings per share for the current year.

Insider Transactions at Phreesia

In other news, SVP Amy Beth Vanduyn sold 1,762 shares of Phreesia stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $23.28, for a total value of $41,019.36. Following the completion of the transaction, the senior vice president owned 112,479 shares in the company, valued at approximately $2,618,511.12. This trade represents a 1.54% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider David Linetsky sold 2,165 shares of the business’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $23.28, for a total value of $50,401.20. Following the transaction, the insider directly owned 174,952 shares of the company’s stock, valued at approximately $4,072,882.56. This represents a 1.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 26,174 shares of company stock valued at $603,835 in the last 90 days. Insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in PHR. Federated Hermes Inc. acquired a new position in shares of Phreesia in the 3rd quarter valued at $32,000. Asset Management One Co. Ltd. purchased a new stake in Phreesia in the third quarter valued at $45,000. State of Alaska Department of Revenue acquired a new position in Phreesia in the third quarter valued at $83,000. Farther Finance Advisors LLC grew its holdings in shares of Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Anchor Investment Management LLC purchased a new position in shares of Phreesia during the third quarter worth about $118,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.